RHUMBLINE ADVISERS - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$123,835
-61.9%
52,476
+1.7%
0.00%
Q2 2023$325,017
+108966.1%
51,590
-0.2%
0.00%
Q1 2023$298
-43.8%
51,688
+0.1%
0.00%
-100.0%
Q4 2022$530
-99.9%
51,616
-0.3%
0.00%0.0%
Q3 2022$866,000
+28.3%
51,772
+7.3%
0.00%0.0%
Q2 2022$675,000
+47.7%
48,228
+70.5%
0.00%0.0%
Q1 2022$457,000
-8.4%
28,284
+21.4%
0.00%0.0%
Q4 2021$499,000
+219.9%
23,289
+119.9%
0.00%
Q3 2021$156,00010,5890.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders